Incidence and Severity of Depression Among Recovered African Americans with COVID-19-Associated Respiratory Failure.
African Americans
COVID-19
Depression
ICU
PHQ-9
Journal
Journal of racial and ethnic health disparities
ISSN: 2196-8837
Titre abrégé: J Racial Ethn Health Disparities
Pays: Switzerland
ID NLM: 101628476
Informations de publication
Date de publication:
06 2022
06 2022
Historique:
received:
13
01
2021
accepted:
29
03
2021
revised:
25
03
2021
pubmed:
8
4
2021
medline:
6
5
2022
entrez:
7
4
2021
Statut:
ppublish
Résumé
Coronavirus disease (COVID-19) disproportionately affects African Americans, and they tend to experience more severe course and adverse outcomes. Using a simple and validated instrument of depression screening, we evaluated the incidence and severity of major depression among African American patients within 90 days of recovery from severe COVID-19-associated respiratory failure. African American patients hospitalized and treated with invasive mechanical ventilation for COVID-19-associated respiratory failure in the intensive care unit (ICU) of Grady Memorial Hospital, Atlanta, between April 1, 2020, and June 30, 2020, were screened for depression within 90 days of hospital discharge using the validated patient health questionnaires (PHQ-2) and PHQ-9. A total of 73 patients completed the questionnaire. The median age was 52.5 years [IQR 44-65] and 65% were males. The most common comorbidities were hypertension (66%) and diabetes mellitus (51%). Forty-four percent of the patients had a diagnosis of major depressive disorder (MDD) based on their PHQ-9 questionnaire responses. The incidence of MDD was higher among females (69%, n=18/26) compared to males (29%, n=14/47), in patients > 75 years (66%) and those with multiple comorbidities (45%). Eighteen percent of the patients had moderate depression, while 15% and 22% had moderately severe and severe depression, respectively. Only 26% (n=7/27) of eligible patients were receiving treatment for depression at the time of this survey. The incidence of depression in a cohort of African American patients without prior psychiatric conditions who recovered from severe COVID-19 infection was 44%. More than 70% of these patients were not receiving treatment for depression.
Sections du résumé
BACKGROUND
Coronavirus disease (COVID-19) disproportionately affects African Americans, and they tend to experience more severe course and adverse outcomes. Using a simple and validated instrument of depression screening, we evaluated the incidence and severity of major depression among African American patients within 90 days of recovery from severe COVID-19-associated respiratory failure.
METHODS
African American patients hospitalized and treated with invasive mechanical ventilation for COVID-19-associated respiratory failure in the intensive care unit (ICU) of Grady Memorial Hospital, Atlanta, between April 1, 2020, and June 30, 2020, were screened for depression within 90 days of hospital discharge using the validated patient health questionnaires (PHQ-2) and PHQ-9.
RESULTS
A total of 73 patients completed the questionnaire. The median age was 52.5 years [IQR 44-65] and 65% were males. The most common comorbidities were hypertension (66%) and diabetes mellitus (51%). Forty-four percent of the patients had a diagnosis of major depressive disorder (MDD) based on their PHQ-9 questionnaire responses. The incidence of MDD was higher among females (69%, n=18/26) compared to males (29%, n=14/47), in patients > 75 years (66%) and those with multiple comorbidities (45%). Eighteen percent of the patients had moderate depression, while 15% and 22% had moderately severe and severe depression, respectively. Only 26% (n=7/27) of eligible patients were receiving treatment for depression at the time of this survey.
CONCLUSION
The incidence of depression in a cohort of African American patients without prior psychiatric conditions who recovered from severe COVID-19 infection was 44%. More than 70% of these patients were not receiving treatment for depression.
Identifiants
pubmed: 33825114
doi: 10.1007/s40615-021-01034-3
pii: 10.1007/s40615-021-01034-3
pmc: PMC8023522
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
954-959Informations de copyright
© 2021. W. Montague Cobb-NMA Health Institute.
Références
JAMA Netw Open. 2020 Jun 1;3(6):e2012270
pubmed: 32543702
Health Aff (Millwood). 2008 Mar-Apr;27(2):393-403
pubmed: 18332495
Arch Gen Psychiatry. 2007 Mar;64(3):305-15
pubmed: 17339519
Brain Behav Immun. 2020 Oct;89:594-600
pubmed: 32738287
J Gen Intern Med. 2005 Aug;20(8):738-42
pubmed: 16050884
Brain Behav Immun. 2020 Jul;87:49-50
pubmed: 32304883
Br J Gen Pract. 2008 Jan;58(546):32-6
pubmed: 18186994
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Ann Thorac Surg. 2013 Sep;96(3):871-7
pubmed: 23866801
J Natl Med Assoc. 2011 Jul;103(7):548-57
pubmed: 21999029
J Med Virol. 2021 Feb;93(2):1013-1022
pubmed: 32729939
J Couns Psychol. 2012 Jan;59(1):1-9
pubmed: 22059427
Front Psychiatry. 2014 Jun 20;5:65
pubmed: 24999332
J Am Med Dir Assoc. 2008 Feb;9(2):82-7
pubmed: 18261699
Lancet Psychiatry. 2021 Feb;8(2):130-140
pubmed: 33181098
Asia Pac Psychiatry. 2013 Dec;5(4):268-75
pubmed: 24123859
Nurs Res. 2012 Sep-Oct;61(5):333-41
pubmed: 22710475
J Intensive Care Soc. 2015 May;16(2):105-108
pubmed: 28979391
Issues Ment Health Nurs. 2013 Feb;34(2):90-102
pubmed: 23369120
JAMA. 2020 May 19;323(19):1891-1892
pubmed: 32293639
J Am Assoc Nurse Pract. 2018 Jul;30(7):406-411
pubmed: 29905589